Amendment · S.Amdt. 2111· Senate(119-SAMDT-2111)
S.Amdt. 2111
Age: 66 years
Minnesota
- Introduced
- 4/4/2025
- Sponsored by
- Amy Klobuchar
- Cosponsors
- None
- Changes bill
- 119-HCONRES-14 — Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth the appropriate budgetary levels for fiscal years 2026 through 2034.
- Introduced
- Pending Consideration
What this amendment would do
This amendment, submitted by Ms. Klobuchar, is officially known as SA 2111. Its purpose is to create a deficit-neutral reserve fund relating to research and product reviews by the Food and Drug Administration for rare diseases.
What It Aims to Change or Add
- Allows the Chairman of the Committee on the Budget of the Senate to revise committee allocations, aggregates, and other appropriate levels in the resolution.
- Permits adjustments to the pay-as-you-go ledger for legislation relating to research and product reviews by the Food and Drug Administration for rare diseases.
- Supports efforts that may include accelerating the development and approval of treatments, improvements in regulatory science, or support for research on innovative therapies.
- Requires that the legislation not increase the deficit over the period of the total of fiscal years 2025 through 2034.
- 4/4/2025
- Senate amendment submitted
This bill has no cosponsors